CARIBOU BIOSCIENCES INC's ticker is and the CUSIP is 142038108. A total of 127 filers reported holding CARIBOU BIOSCIENCES INC in Q1 2023. The put-call ratio across all filers is 1.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $2,783,048 | +27.4% | 541,449 | +42.0% | 0.01% | +11.1% |
Q4 2023 | $2,184,265 | -9.9% | 381,198 | -24.9% | 0.01% | -35.7% |
Q3 2023 | $2,425,372 | +95.4% | 507,400 | +117.0% | 0.01% | +75.0% |
Q1 2023 | $1,241,388 | -6.4% | 233,783 | +10.7% | 0.01% | -27.3% |
Q4 2022 | $1,326,192 | -4.2% | 211,177 | +60.9% | 0.01% | -26.7% |
Q3 2022 | $1,385,000 | – | 131,239 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 544,196 | $5,741,000 | 19.52% |
Elmwood Wealth Management, Inc. | 2,364,240 | $24,943,000 | 12.45% |
72 Investment Holdings, LLC | 474,067 | $5,001,000 | 3.96% |
PFM Health Sciences, LP | 6,000,000 | $63,300,000 | 2.29% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 257,892 | $2,716,000 | 0.87% |
Avidity Partners Management LP | 3,172,600 | $33,471,000 | 0.68% |
Rokos Capital Management LLP | 1,907,509 | $20,811,000 | 0.62% |
Green Alpha Advisors, LLC | 69,376 | $732,000 | 0.62% |
Nelson Capital Management, LLC | 85,020 | $897,000 | 0.26% |
Tekla Capital Management LLC | 567,147 | $5,983,000 | 0.24% |